Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NIH Consensus 1994: screening

B S Kramer1, J Gohagan, P C Prorok

  • 1Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Maryland 20892.

Gynecologic Oncology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active follow-up versus passive linkage with cancer registries for case ascertainment in a cohort.

Cancer epidemiology·2016
Same author

Five-alpha-reductase Inhibitors for prostate cancer prevention.

The Cochrane database of systematic reviews·2008
Same author

Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.

American journal of epidemiology·2007
Same author

Trends in biomarker research for cancer detection.

The Lancet. Oncology·2002
Same author

Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies.

Journal of women's health & gender-based medicine·2001
Same author

The paired availability design for historical controls.

BMC medical research methodology·2001
Same journal

Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data.

Gynecologic oncology·2026
Same journal

Adjunctive sodium-glucose cotransporter 2 (SGLT2) inhibitors with progestins and endometrial cancer risk in benign uterine diseases and hyperplasia.

Gynecologic oncology·2026
Same journal

Updated patient-reported outcomes and the effect of disease progression on health-related quality of life in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer.

Gynecologic oncology·2026
Same journal

PRO-PLATINUM: A randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic intervention on the gut and vaginal microbiome of ovarian cancer patients undergoing treatment with platinum chemotherapy.

Gynecologic oncology·2026
Same journal

A second chance for the second look: Feasibility of laparoscopic HIPEC at the conclusion of upfront treatment for epithelial ovarian cancer.

Gynecologic oncology·2026
Same journal

Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network.

Gynecologic oncology·2026
See all related articles

Early cancer detection does not always benefit patients. Rigorous scientific evidence is needed to confirm the effectiveness of screening methods, especially for ovarian cancer detection in asymptomatic women.

Area of Science:

  • Oncology
  • Public Health
  • Epidemiology

Background:

  • The common assumption that earlier cancer diagnosis automatically confers benefit is being challenged by emerging screening science.
  • Public health recommendations increasingly rely on evidence-based approaches for new screening technologies.

Framework:

  • The science of screening provides a rigorous framework for evaluating diagnostic tests.
  • An evidence-based approach is crucial for determining the utility of screening and early detection methods.

Implementation:

  • Current early detection methods for ovarian cancer show limited evidence for routine use in asymptomatic women.
  • The National Cancer Institute has initiated a large randomized clinical trial to assess ovarian cancer screening effectiveness.

Related Experiment Videos

Implications:

  • Rigorous evaluation is necessary before widespread adoption of cancer screening tests.
  • The findings will inform public health policy and clinical guidelines for ovarian cancer screening.